economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

approves

FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer’s Disease in the US

FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer’s Disease in the US

creativebharatgroup@gmail.com January 27, 2025
Stockholm, January 27, 2025 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today...
Read More Read more about FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer’s Disease in the US
Indian Oil to be biggest beneficiary if Finance Ministry approves compensation for LPG under-recoveries LPG-shutterstock.jpg

Indian Oil to be biggest beneficiary if Finance Ministry approves compensation for LPG under-recoveries

creativebharatgroup@gmail.com December 20, 2024
The total LPG under-recoveries in the first half of financial year 2024-25 have come to ₹17,500 crore,...
Read More Read more about Indian Oil to be biggest beneficiary if Finance Ministry approves compensation for LPG under-recoveries
RBI approves Burman family entities’ open offer to acquire 26 pc additional stake in REL, ET Retail 116174586.cms

RBI approves Burman family entities’ open offer to acquire 26 pc additional stake in REL, ET Retail

creativebharatgroup@gmail.com December 10, 2024
The Reserve Bank has approved the open offer of Burman family — the promoters of FMCG major...
Read More Read more about RBI approves Burman family entities’ open offer to acquire 26 pc additional stake in REL, ET Retail
U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting OG_NewsReleaseCompanyLogo_92662.jpg

U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting

creativebharatgroup@gmail.com November 27, 2024
Vienna, Austria:   AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria,...
Read More Read more about U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting